Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Mountz

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Molecular imaging: new applications for biochemistryJohn D Mountz, Hui-Chen Hsu, Qi Wu, et al.
Journal of Periodontology|April 17, 2015
Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal DiseasesLiang Hao, Jianwei Chen, Zheng Zhu, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2025
IL-4 alters TLR7-induced B cell developmental program in lupusChangming Lu, Shanrun Liu, Min Gao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APCSabine Hoves, Stefan W Krause, Dagmar Halbritter, et al.
Journal of Virology|November 5, 2002
Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or productionHuang-Ge Zhang, Jinfu Xie, Igor Dmitriev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 miceHao Li, Qi Wu, Jun Li, et al.
Immunobiology|May 6, 2004
Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cellsSabine Hoves, Stefan W Krause, Hans Herfarth, et al.
Arthritis and Rheumatism|July 3, 2013
Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritisJun Li, PingAr Yang, Qi Wu, et al.
Plos One|August 6, 2014
Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupusAllison Sang, Ying-Yi Zheng, Yiming Yin, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Molecular imaging: new applications for biochemistryJohn D Mountz, Hui-Chen Hsu, Qi Wu, et al.
Journal of Periodontology|April 17, 2015
Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal DiseasesLiang Hao, Jianwei Chen, Zheng Zhu, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2025
IL-4 alters TLR7-induced B cell developmental program in lupusChangming Lu, Shanrun Liu, Min Gao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APCSabine Hoves, Stefan W Krause, Dagmar Halbritter, et al.
Journal of Virology|November 5, 2002
Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or productionHuang-Ge Zhang, Jinfu Xie, Igor Dmitriev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 miceHao Li, Qi Wu, Jun Li, et al.
Immunobiology|May 6, 2004
Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cellsSabine Hoves, Stefan W Krause, Hans Herfarth, et al.
Arthritis and Rheumatism|July 3, 2013
Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritisJun Li, PingAr Yang, Qi Wu, et al.
Plos One|August 6, 2014
Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupusAllison Sang, Ying-Yi Zheng, Yiming Yin, et al.
Pageof 9